CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients (CLOTILDIA) CLOpidogrel versus TIcagreLor per la terapia antiaggregante di mantenimento nei pazienti DIAbetici sottoposti ad angioplastica coronarica(CLOTILDIA)

Trial Profile

CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients (CLOTILDIA) CLOpidogrel versus TIcagreLor per la terapia antiaggregante di mantenimento nei pazienti DIAbetici sottoposti ad angioplastica coronarica(CLOTILDIA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
  • Indications Diabetic angiopathies
  • Focus Therapeutic Use
  • Acronyms CLOTILDIA
  • Most Recent Events

    • 14 Apr 2016 Status changed from recruiting to completed.
    • 09 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top